2018.09.03
Press Release
intellim’s Business Development Plan (Announcement on the Establishment of intellim Holdings Corporation)
This is to inform you that intellim Holdings Co., Ltd. will be in full operation from September 2018.
Going forward, intellim Holdings Co., Ltd. will act as the core of the group affiliates and will lead each company, including intellim Co., Ltd., to improve the efficiency of business operations.
Group affiliates and main business fields as of September 2018
| intellim Holdings Corporation | intellim Corporation Drug Development Services and Consultation Services in Japan |
|---|---|
| intellim Korea Corporation Drug Development Services and Consultation Services in Korea |
|
| intellim Malaysia SDN.BHD. Drug Development Services and Consultation Services in Malaysia |
|
| iRIS Corporation SMO Business Specialized in the Field of Regenerative Medicine |
|
| iQ Pharma Services Corporation Drug Development Services and Consultation Services in Asia |
|
| intellim Taiwan (Representative Office) Drug Development Services and Consultation Services in Taiwan |